These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25469920)

  • 1. Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.
    Bhatnagar V; Wu Y; Goloubeva OG; Ruehle KT; Milliron TE; Harris CG; Rapoport AP; Yanovich S; Sausville EA; Baer MR; Badros AZ
    Cancer; 2015 Apr; 121(7):1064-70. PubMed ID: 25469920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review.
    Lupak O; Xiaoxia H; Xie P; Thanikachalam K; Jabbour-Aida H; Farhan S; Emole J
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e680-e685. PubMed ID: 34148850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma.
    Sweiss K; Oh A; Calip GS; Rondelli D; Patel P
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e506-e511. PubMed ID: 31231013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
    Schriber JR; Hari PN; Ahn KW; Fei M; Costa LJ; Kharfan-Dabaja MA; Angel-Diaz M; Gale RP; Ganguly S; Girnius SK; Hashmi S; Pawarode A; Vesole DH; Wiernik PH; Wirk BM; Marks DI; Nishihori T; Olsson RF; Usmani SZ; Mark TM; Nieto YL; D'Souza A
    Cancer; 2017 Aug; 123(16):3141-3149. PubMed ID: 28472539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.
    Hari PN; Majhail NS; Zhang MJ; Hassebroek A; Siddiqui F; Ballen K; Bashey A; Bird J; Freytes CO; Gibson J; Hale G; Holmberg L; Kamble R; Kyle RA; Lazarus HM; LeMaistre CF; Loberiza F; Maiolino A; McCarthy PL; Milone G; Omondi N; Reece DE; Seftel M; Trigg M; Vesole D; Weiss B; Wiernik P; Lee SJ; Rizzo JD; Mehta P
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):395-402. PubMed ID: 19922808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
    Badar T; Hari P; Dávila O; Fraser R; Wirk B; Dhakal B; Freytes CO; Rodriguez Valdes C; Lee C; Vesole DH; Malek E; Hildebrandt GC; Landau H; Murthy HS; Lazarus HM; Berdeja JG; Meehan KR; Solh M; Diaz MA; Kharfan-Dabaja MA; Callander NS; Farhadfar N; Bashir Q; Kamble RT; Vij R; Munker R; Kyle RA; Chhabra S; Hashmi S; Ganguly S; Jagannath S; Nishihori T; Nieto Y; Kumar S; Shah N; D'Souza A
    Cancer; 2021 Jan; 127(1):82-92. PubMed ID: 32966625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Race and Time to Transplantation in Multiple Myeloma: The Mount Sinai Hospital Experience.
    Pan D; Coltoff A; Ozbek U; Lin JY; Afshar S; Galitzeck Z; Steinberg A
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):439-443. PubMed ID: 33757769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
    Gay F; Musto P; Rota-Scalabrini D; Bertamini L; Belotti A; Galli M; Offidani M; Zamagni E; Ledda A; Grasso M; Ballanti S; Spadano A; Cea M; Patriarca F; D'Agostino M; Capra A; Giuliani N; de Fabritiis P; Aquino S; Palmas A; Gamberi B; Zambello R; Petrucci MT; Corradini P; Cavo M; Boccadoro M
    Lancet Oncol; 2021 Dec; 22(12):1705-1720. PubMed ID: 34774221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.
    Verma PS; Howard RS; Weiss BM
    Am J Hematol; 2008 May; 83(5):355-8. PubMed ID: 18186525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience.
    Bierenbaum J; Davidoff AJ; Ning Y; Tidwell ML; Gojo I; Baer MR
    Leuk Res; 2012 Feb; 36(2):140-5. PubMed ID: 22112974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
    Costa LJ; Brill IK; Brown EE
    Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents.
    Al-Hamadani M; Hashmi SK; Go RS
    Am J Hematol; 2014 Aug; 89(8):825-30. PubMed ID: 24799343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in treatment use for multiple myeloma.
    Fiala MA; Wildes TM
    Cancer; 2017 May; 123(9):1590-1596. PubMed ID: 28085188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
    Veltri LW; Milton DR; Delgado R; Shah N; Patel K; Nieto Y; Kebriaei P; Popat UR; Parmar S; Oran B; Ciurea S; Hosing C; Lee HC; Manasanch E; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q
    Cancer; 2017 Sep; 123(18):3568-3575. PubMed ID: 28513828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to hematopoietic stem cell transplantation: effect of race and sex.
    Joshua TV; Rizzo JD; Zhang MJ; Hari PN; Kurian S; Pasquini M; Majhail NS; Lee SJ; Horowitz MM
    Cancer; 2010 Jul; 116(14):3469-76. PubMed ID: 20564154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
    Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
    Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.
    Rosenberg AS; Brunson A; Jonas BA; Keegan THM; Wun T
    J Natl Cancer Inst; 2019 Jan; 111(1):78-85. PubMed ID: 29897481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.